The Lancet Oncology is an authoritative forum for key opinion leaders across medicine, government, and health systems to influence clinical practice, explore global policy, and inform constructive, positive change worldwide.
As the global leader in clinical oncology research, The Lancet Oncology delivers essential original research, expert review, candid commentary, and breaking news to provide context and perspective on today's most important medical advances across the broad spectrum of oncology.
With an impact factor of 24.725, the journal ranks third out of 202 oncology journals worldwide, is the leading clinical research journal in oncology, and is in the top 0.5% of all scientific journals, of any discipline, globally. (2013 Journal Citation Reports®, © 2014 Thomson Reuters)
The Lancet Oncology is stringently edited and peer-reviewed to ensure the scientific merit and clinical relevance of its diverse content. All original research is Fast Tracked to publication within 8 weeks of submission and published Online First on thelancet.com before the print issue. Articles published in the journal regularly receive coverage in the mainstream print, online, and broadcast media.Visit www.TheLancet.com to find out more about The Lancet Oncology.
For the complete instructions visit The Lancet.com